CH Biotech R&D Co., Ltd. (TPE:6534)

CH Biotech R&D Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,684	1,636	1,515	1,434	1,019	702.19
Revenue Growth (YoY)	13.79%	7.98%	5.63%	40.81%	45.05%	-16.47%
Cost of Revenue	278.55	270.92	254.73	299.52	170.56	112.18
Gross Profit	1,406	1,365	1,260	1,135	847.95	590.01
Selling, General & Admin	492.95	459.16	389	351.12	267.2	251.6
Research & Development	370.5	363.36	305.24	272.41	221.48	193.34
Operating Expenses	873.89	822.52	694.24	623.54	488.68	444.93
Operating Income	531.9	542.3	565.86	511.06	359.27	145.07
Interest Expense	-15.98	-15	-16.81	-16.81	-13.9	-22.74
Interest & Investment Income	13.79	18.8	17.22	5.12	0.6	1.52
Earnings From Equity Investments	-1.42	-0.26	-0.05	-	-	-
Currency Exchange Gain (Loss)	39.58	39.58	7.18	62.28	-12.15	-24.51
Other Non Operating Income (Expenses)	-128.35	5.54	4.46	3.59	25.69	26.84
EBT Excluding Unusual Items	439.51	590.96	577.86	565.23	359.5	126.19
Gain (Loss) on Sale of Assets	0.31	0.31	1.07	0.57	0.11	0.04
Other Unusual Items	1.69	1.69	-	-	0.04	1.17
Pretax Income	441.51	592.96	578.93	565.8	359.65	127.39
Income Tax Expense	77.7	117.27	115.64	100.37	68.15	27.23
Earnings From Continuing Operations	363.81	475.69	463.29	465.42	291.5	100.16
Minority Interest in Earnings	0.49	0.7	-	-	-	-
Net Income	364.31	476.39	463.29	465.42	291.5	100.16
Net Income to Common	364.31	476.39	463.29	465.42	291.5	100.16
Net Income Growth	-15.21%	2.83%	-0.46%	59.66%	191.03%	-47.41%
Shares Outstanding (Basic)	103	103	97	97	97	97
Shares Outstanding (Diluted)	103	103	98	99	98	98
Shares Change (YoY)	3.07%	5.50%	-0.77%	0.54%	0.44%	-0.37%
EPS (Basic)	3.54	4.63	4.76	4.79	3.00	1.03
EPS (Diluted)	3.53	4.61	4.73	4.72	2.97	1.03
EPS Growth	-17.66%	-2.54%	0.21%	58.92%	189.44%	-47.08%
Free Cash Flow	164.33	-49.98	545.47	585.08	192.43	125.03
Free Cash Flow Per Share	1.59	-0.48	5.57	5.93	1.96	1.28
Dividend Per Share	3.600	4.100	4.090	3.880	1.304	0.435
Dividend Growth	0.28%	0.24%	5.41%	197.48%	199.98%	-52.27%
Gross Margin	83.46%	83.44%	83.18%	79.11%	83.25%	84.02%
Operating Margin	31.58%	33.15%	37.35%	35.64%	35.27%	20.66%
Profit Margin	21.63%	29.12%	30.58%	32.45%	28.62%	14.26%
Free Cash Flow Margin	9.76%	-3.06%	36.01%	40.80%	18.89%	17.80%
EBITDA	707.55	704.78	703.17	628.06	435.89	223.8
EBITDA Margin	42.01%	43.09%	46.42%	43.79%	42.80%	31.87%
D&A For EBITDA	175.65	162.48	137.31	117.01	76.62	78.73
EBIT	531.9	542.3	565.86	511.06	359.27	145.07
EBIT Margin	31.58%	33.15%	37.35%	35.64%	35.27%	20.66%
Effective Tax Rate	17.60%	19.78%	19.98%	17.74%	18.95%	21.38%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.